Literature DB >> 23307225

Optic disc edema from remote uveal melanoma.

Sireesha A Clark, Martin Lubow, Abhik Ray-Chaudhury, Frederick H Davidorf, Mohamed H Abdel-Rahman, Colleen M Cebulla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23307225      PMCID： PMC5298927          DOI： 10.1001/jamaophthalmol.2013.575

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  6 in total

1.  Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.

Authors:  Luz Maria Vásquez; Sohel Somani; Filiberto Altomare; E Rand Simpson
Journal:  Can J Ophthalmol       Date:  2009-02       Impact factor: 1.882

2.  Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.

Authors:  Hadas Newman; Paul T Finger; Kimberly J Chin; Anna C Pavlick
Journal:  Eur J Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 2.597

3.  Vascular endothelial growth factor a in eyes with uveal melanoma.

Authors:  Guy S O Missotten; Irene C Notting; Reinier O Schlingemann; Henry J Zijlmans; Chun Lau; Paul H C Eilers; Jan E E Keunen; Martine J Jager
Journal:  Arch Ophthalmol       Date:  2006-10

4.  Mechanisms of optic disc swelling with diffuse choroidal melanomas: clinicopathologic correlations.

Authors:  G C Brown; J A Shields
Journal:  Br J Ophthalmol       Date:  1982-02       Impact factor: 4.638

5.  Cystoid macular edema with equatorial choroidal melanoma.

Authors:  S Brownstein; R Orton; B Jackson
Journal:  Arch Ophthalmol       Date:  1978-11

6.  Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor.

Authors:  S A Vinores; M Küchle; J Mahlow; C Chiu; W R Green; P A Campochiaro
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307
  6 in total
  1 in total

1.  [Choroidal tumor with accompanying papilledema].

Authors:  T J Mäueler; M Ulbig; K H Eibl-Lindner
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.